*The following content is generated by AI and is for reference only.
<h3>Overview</h3>
<p>Azelnidipine is a third-generation dihydropyridine calcium channel blocker used primarily in hypertension management. Its core synthesis involves <strong>enantioselective cyclization</strong> of specific intermediates. Molecular formula: <strong>C28H30N2O6</strong>; CAS No: <strong>117956-40-4</strong>.</p>
<h3>Application</h3>
<ul>
<li><strong>Pharmaceutical Manufacturing</strong>: Production of antihypertensive tablets for chronic cardiovascular therapy.</li>
<li><strong>Research & Development</strong>: Active Pharmaceutical Ingredient (API) supply for clinical trials on vascular resistance.</li>
<li><strong>Distribution</strong>: Wholesale supply to regional wholesalers and hospital formularies.</li>
</ul>
<h3>Precautions</h3>
<p>Contraindicated in patients with severe hypotension or acute myocardial infarction. Store API in sealed containers at 2–8°C, protected from moisture and direct light to maintain stability.</p>